Article
Characteristics of HPRT-mutant T cell lines in a lupus patient treated with cyclophosphamide.
Arthritis and rheumatism - 1 Oct 1994
Wood G M, Dawisha S, Gourley M
Abstract excerpt
This report describes T cell lines derived from a patient with subacute cutaneous lupus after treatment with intravenous pulse cyclophosphamide. We selected for mitotically active, hypoxanthine-guanine phosphoribosyltransferase-deficient (HPRT-) T cells, by culture in a selective medium containing 6-thioguanine. When HPRT- cell lines were derived 6 days after pulse cyclophosphamide (CYC) treatment, they were...
Topics
- Adult
- CD4-Positive T-Lymphocytes
- CD8-Positive T-Lymphocytes
- Cell Line
- Cyclophosphamide
- Female
- Humans
- Hypoxanthine Phosphoribosyltransferase
- Infusions, Intravenous
- Lupus Erythematosus, Systemic
- Mutation
